NasdaqCM - Delayed Quote USD

LakeShore Biopharma Co., Ltd (LSBPW)

Compare
0.0800
+0.0211
+(35.82%)
At close: January 31 at 4:00:00 PM EST
All numbers in thousands
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
1,513,027.3560
1,719,753.6110
1,441,753.1410
1,167,175.0720
Total Liabilities Net Minority Interest
927,821.0540
991,300.3260
2,140,722.3290
1,676,037.7790
Total Equity Gross Minority Interest
585,206.3020
728,453.2850
-698,969.1880
-508,862.7070
Total Capitalization
684,190.0820
1,022,243.8810
-445,041.1880
-507,759.0980
Preferred Stock Equity
--
--
1,370,221.3920
1,285,458.5710
Common Stock Equity
585,206.3020
728,453.2850
-698,969.1880
-508,862.7070
Capital Lease Obligations
6,940.1330
11,102.4370
14,927.5120
17,336.0010
Net Tangible Assets
513,960.9660
650,396.4930
-779,687.1660
-592,641.3100
Working Capital
100,942.2200
377,216.7200
288,850.2330
388,163.2920
Invested Capital
1,002,730.8140
1,215,980.4440
-333,307.4340
-507,759.0980
Tangible Book Value
513,960.9660
650,396.4930
-779,687.1660
-592,641.3100
Total Debt
424,464.6450
498,629.5960
380,589.2660
18,439.6100
Net Debt
171,173.2810
117,419.1000
94,594.2510
--
Share Issued
188,327.9590
93,058.1970
92,174.9950
92,174.9950
Ordinary Shares Number
188,327.9590
93,058.1970
92,174.9950
92,174.9950
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers